semaglutide chf aids weight loss in people with heart failure, improves symptoms The schematic model shows patients

Ongoing monitoring includes TSH assessment 68 weeks after starting weight loss injections or dose changes, then every 612 months if stable, with levothyroxine adjustment as needed

Warfarin: Rybelsus may affect the absorption of warfarin (a blood thinner), increasing the risk of side effects

No, these medications require professional monitoring

Signs and symptoms that may indicate low blood sugar include: o dizziness or light-headedness o blurred vision o anxiety, irritability, or mood changes o sweating o slurred speech o hunger o confusion o shakiness o headache o fast heartbeat Low potassium in your blood (hypokalemia)

Diabetes medications based on semaglutide deliver important cardiovascular benefits, according to a new meta-analysis